Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N JONES

Showing results (381-390 of 945) with videos related to

Pageof 95
Sort By:
International Journal of Antimicrobial Agents|August 5, 2000
Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areasR N Jones, M A Pfaller, M E Erwin
Diagnostic Microbiology and Infectious Disease|December 1, 1999
Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest method. Venezuelan Antimicrobial Resistance Study GroupM A Pfaller, R N Jones, G V Doern
Diagnostic Microbiology and Infectious Disease|June 23, 2000
Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methodsR N Jones, D J Biedenbach, D M Johnson
Diagnostic Microbiology and Infectious Disease|July 1, 1993
In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolonesD M Johnson, R N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|January 1, 1992
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overviewD J Hardy, D R Guay, R N Jones
Journal of Clinical Microbiology|October 9, 2004
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazoleM A Pfaller, A Espinel-Ingroff, R N Jones
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing EnterobacteriaceaeH S Sader, M A Pfaller, R N Jones
Diagnostic Microbiology and Infectious Disease|May 1, 1994
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study GroupM J Bale, R N Jones, M E Erwin
American Journal of Clinical Pathology|October 1, 1983
Contemporary quality control practices for antimicrobial susceptibility tests: a report from the microbiology portion of the College of American Pathologists (CAP) surveys programR N Jones, D C Edson, B F Gilmore
Journal of Clinical Microbiology|October 1, 1993
Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganiiD J Biedenbach, R N Jones, M E Erwin
Pageof 95

Showing results (381-390 of 945) with videos related to

Sort By:
Pageof 95
International Journal of Antimicrobial Agents|August 5, 2000
Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areasR N Jones, M A Pfaller, M E Erwin
Diagnostic Microbiology and Infectious Disease|December 1, 1999
Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest method. Venezuelan Antimicrobial Resistance Study GroupM A Pfaller, R N Jones, G V Doern
Diagnostic Microbiology and Infectious Disease|June 23, 2000
Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methodsR N Jones, D J Biedenbach, D M Johnson
Diagnostic Microbiology and Infectious Disease|July 1, 1993
In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolonesD M Johnson, R N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|January 1, 1992
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overviewD J Hardy, D R Guay, R N Jones
Journal of Clinical Microbiology|October 9, 2004
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazoleM A Pfaller, A Espinel-Ingroff, R N Jones
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing EnterobacteriaceaeH S Sader, M A Pfaller, R N Jones
Diagnostic Microbiology and Infectious Disease|May 1, 1994
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study GroupM J Bale, R N Jones, M E Erwin
American Journal of Clinical Pathology|October 1, 1983
Contemporary quality control practices for antimicrobial susceptibility tests: a report from the microbiology portion of the College of American Pathologists (CAP) surveys programR N Jones, D C Edson, B F Gilmore
Journal of Clinical Microbiology|October 1, 1993
Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganiiD J Biedenbach, R N Jones, M E Erwin
Pageof 95